BioStable Science & Engineering has received FDA market clearance for its HAART 300 aortic annuloplasty device.

The device is designed to re-size, reshape and stabilize the aortic annulus to restore valve competence and help prevent recurrent aortic regurgitation.

The device received CE Mark approval in 2016. — Cynthia Jessup